Gut,
Journal Year:
2024,
Volume and Issue:
73(11), P. 1893 - 1908
Published: Sept. 25, 2024
The
understanding
that
changes
in
microbiome
composition
can
influence
chronic
human
diseases
and
the
efficiency
of
therapies
has
driven
efforts
to
develop
microbiota-centred
such
as
first
next
generation
probiotics,
prebiotics
postbiotics,
microbiota
editing
faecal
transplantation.
Central
research
is
how
disease
impacts
vice
versa,
yet
there
a
problematic
issue
with
term
'dysbiosis',
which
broadly
links
microbial
imbalances
various
illnesses
without
precision
or
definition.
Another
significant
discussions
defining
'healthy
individuals'
ascertain
what
characterises
healthy
microbiome.
This
involves
questioning
who
represents
healthiest
segment
our
population-whether
it
those
free
from
illnesses,
athletes
at
peak
performance,
individuals
living
healthily
through
regular
exercise
good
nutrition
even
elderly
adults
centenarians
have
been
tested
by
time
achieved
remarkable
longevity.This
review
advocates
for
delineating
'what
defines
microbiome?'
considering
broader
range
factors
related
health
environmental
influences
on
microbiota.
A
undoubtedly
linked
gut
health.
Nevertheless,
very
difficult
pinpoint
universally
accepted
definition
'gut
health'
due
complexities
measuring
functionality
besides
composition.
We
must
take
into
account
individual
variabilities,
diet,
lifestyle,
host
factors.
Moreover,
challenge
distinguishing
causation
correlation
between
overall
presented.The
also
highlights
resource-heavy
nature
comprehensive
assessments,
hinders
their
practicality
broad
application.
Finally,
we
call
continued
nuanced
approach
better
understand
intricate
evolving
concept
health,
emphasising
need
more
precise
inclusive
definitions
methodologies
studying
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 14, 2025
Human
gut
Bacteroides
and
Parabacteroides
species
play
crucial
roles
in
human
health
are
known
for
their
capacity
to
utilize
diverse
polysaccharides.
Understanding
how
these
bacteria
medicinal
polysaccharides
is
foundational
developing
polysaccharides-based
prebiotics
drugs.
Here,
we
systematically
mapped
the
utilization
profiles
of
20
different
by
28
species.
The
growth
exhibited
substantial
variation
across
bacterial
Ginseng
promoted
multiple
species;
contrast,
Dendrobium
selectively
uniformis.
This
distinct
profile
was
associated
with
genomic
carbohydrate-active
enzymes,
rather
than
monosaccharides
composition
among
Through
comparative
transcriptomics
genetical
manipulation,
validated
that
polysaccharide
locus
PUL34_Bu
enabled
uniformis
(i.e.
glucomannan).
In
addition,
found
GH26
enzyme
allowed
plant-derived
mannan.
Overall,
our
results
revealed
selective
provided
insights
into
use
engineering
microbiome.
authors
characterize
species,
revealing
variability
responses,
which
they
link
differences
enzymes.
The
relationship
between
the
gut
microbiome
and
metabolic
dysfunction-associated
fatty
liver
disease
(MAFLD)
has
garnered
increasing
attention.
However,
association
dietary
index
for
microbiota
(DI-GM),
a
measure
of
diversity,
MAFLD
yet
to
be
fully
explored.
Data
from
2017-2020
National
Health
Nutrition
Examination
Survey
(NHANES)
were
analyzed,
including
7243
participants.
DI-GM
was
investigated
using
weighted
logistic
regression,
restricted
cubic
spline
(RCS),
subgroup
analyses.
A
notable
inverse
identified
prevalence
MAFLD,
with
each
1-point
increase
in
corresponding
6.1%
reduction
(OR
=
0.939,
95%
CI:
0.901-0.980).
Individuals
score
6
or
higher
had
an
adjusted
OR
0.794
(95%
0.665-0.947)
compared
those
0-3.
RCS
analysis
further
revealed
linear
risk.
Additionally,
analyses
suggested
that
race
may
modify
(P
interaction
<
0.05).
is
inversely
associated
prevalence,
appears
significant
modifier
this
relationship.
Abstract
Recent
advances
in
understanding
the
modulatory
functions
of
gut
and
microbiota
on
human
diseases
facilitated
our
focused
attention
contribution
to
pathophysiological
alterations
many
extraintestinal
organs,
including
liver,
heart,
brain,
lungs,
kidneys,
bone,
skin,
reproductive,
endocrine
systems.
In
this
review,
we
applied
“gut–X
axis”
concept
describe
linkages
between
other
organs
discussed
latest
findings
related
axis,”
underlying
mechanisms
potential
clinical
intervention
strategies.
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: July 16, 2024
Necrotizing
enterocolitis
(NEC)
is
a
leading
cause
of
morbidity
and
mortality
in
premature
infants
with
no
specific
treatments
available.
We
aimed
to
identify
the
molecular
mechanisms
underlying
NEC
investigate
therapeutic
effects
Bacteroides
fragilis
on
NEC.
Clinical
samples
infant
feces,
bile
acid-targeted
metabolomics,
pathological
staining,
bioinformatics
analysis,
rat
model,
co-immunoprecipitation
were
used
explore
pathogenesis
Taxonomic
characterization
salt
hydrolase
(bsh)
gene,
enzyme
activity
assays,
16S
rRNA
sequencing,
organoids
B.
NEC-related
intestinal
damage.
samples,
models,
vitro
experiments
revealed
that
total
acid
increased
blood
but
decreased
feces.
Moreover,
levels
FXR
other
metabolism-related
genes
abnormal,
resulting
disordered
metabolism
Taurochenodeoxycholic
accelerated
taurodeoxycholate
alleviated
displayed
bsh
damage
by
restoring
gut
microbiota
dysbiosis
abnormalities
inhibiting
FXR-NLRP3
signaling
pathway.
Our
results
provide
valuable
insights
into
role
Administering
may
substantially
alleviate
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: July 24, 2024
Commensal
microorganisms
in
the
human
gut
produce
numerous
metabolites
by
using
small
molecules
derived
from
host
or
diet
as
precursors.
Host
dietary
lipid
are
involved
energy
metabolism
and
maintaining
structural
integrity
of
cell
membranes.
Notably,
microbes
can
convert
these
lipids
into
bioactive
signaling
through
their
biotransformation
synthesis
pathways.
These
microbiota-derived
affect
physiology
influencing
body's
immune
metabolic
processes.
This
review
aims
to
summarize
recent
advances
microbial
transformation
immunomodulatory
functions
metabolites,
with
a
special
focus
on
fatty
acids
steroids
produced
our
microbiota.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(1), P. 56 - 56
Published: Jan. 6, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
prevalent
chronic
condition
marked
by
excessive
lipid
accumulation
in
hepatic
tissue.
This
disorder
can
lead
to
range
of
pathological
outcomes,
including
metabolic
steatohepatitis
(MASH)
and
cirrhosis.
Despite
extensive
research,
the
molecular
mechanisms
driving
MASLD
initiation
progression
remain
incompletely
understood.
Oxidative
stress
peroxidation
are
pivotal
"multiple
parallel
hit
model",
contributing
cell
death
tissue
damage.
Gut
microbiota
plays
substantial
role
modulating
oxidative
through
multiple
pathways:
impairing
intestinal
barrier,
which
results
bacterial
translocation
inflammation;
modifying
bile
acid
structure,
impacts
signaling
cascades
involved
lipidic
metabolism;
influencing
hepatocytes'
ferroptosis,
form
programmed
death;
regulating
trimethylamine
N-oxide
(TMAO)
activating
platelet
function,
both
recently
identified
as
pathogenetic
factors
MASH
progression.
Moreover,
various
exogenous
impact
gut
its
involvement
MASLD-related
stress,
such
air
pollution,
physical
activity,
cigarette
smoke,
alcohol,
dietary
patterns.
manuscript
aims
provide
state-of-the-art
overview
focused
on
intricate
interplay
between
microbiota,
peroxidation,
pathogenesis,
offering
insights
into
potential
strategies
prevent
associated
complications.